Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Therapeutische Umschau. Revue Therapeutique|February 28, 2015
[In Process Citation]Hans-Peter Marti, Christina Dörje, Erik H Strøm
Diagnostic Pathology|July 11, 2015
The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lungTrond-Eirik Strand, Hans Rostad, Erik H Strøm, et al.
The Journal of Infection|September 4, 2010
A large outbreak of Listeria monocytogenes infection with short incubation period in a tertiary care hospitalBjørn Odd Johnsen, Egil Lingaas, Dag Torfoss, et al.
Ultrastructural Pathology|February 18, 2011
Lecithin: Cholesterol Acyltransferase (LCAT) Deficiency: renal lesions with early graft recurrenceErik H Strøm, Ståle Sund, Morten Reier-Nilsen, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|October 11, 2017
Anterior Ischemic Optic Neuropathy Due to CalciphylaxisMagne S Sivertsen, Erik H Strøm, Kim M A Endre, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 1, 2008
Niemann-Pick disease type C2 presenting as fatal pulmonary alveolar lipoproteinosis: morphological findings in lung and nervous tissueBjörn Bjurulf, Signe Spetalen, Aage Erichsen, et al.
European Radiology|May 22, 2012
Tissue elasticity estimated by acoustic radiation force impulse quantification depends on the applied transducer force: an experimental study in kidney transplant patientsTrygve Syversveen, Karsten Midtvedt, Audun E Berstad, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|August 30, 2011
Non-invasive assessment of renal allograft fibrosis by dynamic sonographic tissue perfusion measurementTrygve Syversveen, Knut Brabrand, Karsten Midtvedt, et al.
NDT Plus|June 29, 2017
Fabry disease in donor kidneys with 3- and 12-year follow-up after transplantationWilly Aasebø, Erik H Strøm, Torstein Hovig, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
Associations between TS, TTF-1, FR-α, FPGS, and overall survival in patients with advanced non-small-cell lung cancer receiving pemetrexed plus carboplatin or gemcitabine plus carboplatin as first-line chemotherapyBjørn H Grønberg, Marius Lund-Iversen, Erik H Strøm, et al.
Pageof 3